Tom 17, Nr 4 (2024)
Sprawozdanie z konferencji / Sprawozdanie
Opublikowany online: 2024-12-23
Wyświetlenia strony
13
Wyświetlenia/pobrania artykułu
9
Wybrane doniesienia dotyczące terapii komórkowych — 38. Międzynarodowy Kongres International Society of Blood Transfusion (ISBT) w Barcelonie
DOI: 10.5603/jtm.103729
Journal of Transfusion Medicine 2024;17(4):198-202.
Streszczenie
Brak
Referencje
- Querol S, Rudilla F, Castillo N, et al. Adoptive immunotherapy with virus-specific T cells in immunocompromised patients. Vox Sang. 2024; 119(S1): LD03–L01.
- Bönig HB. Characteristics of apheresis products and CAR-T cell therapeutic outcomes. Vox Sang. 2024; 119(S1)(60): PA14–L01.
- Yoshida M, Maruoka H, Yonetani N, et al. Analysis of cytokine release syndrome related factors after chimeric antigen receptor T cell therapy. Vox Sang. 2024; 119(S1)(60): PA14–L04.
- Blake JT, Allen D, Ganz K, et al. Evaluating the effectiveness of stem cell recruiting policies using a dynamic registry simulation. Vox Sang. 2024; 119(S1)(568): P868.
- Fernandez J, Gomez D, Castillo-Flores N, et al. To wash or not to wash cryopreserved unrelated peripheral blood stem cells for transplantation? Vox Sang. 2024; 119(S1)(574): P878.
- Tobalina Ga, Navarro GM, Alonso JR, et al. Is total cell recovery a surrogate marker for the quality of cryopreserved peripheral blood apheresis products? Vox Sang. 2024; 119(S1)(576): P885.
- Bonchi C, Mele M, Prisciandaro M, et al. Bed-side versus on-site thawing of cryopreserved hematopoietic stem cells. Vox Sang. 2024; 119(S1)(583): P898.
- Yamazaki R, Tanaka Y, Igarashi Y, et al. Possibility of Hemopoietic Progenitor Cells (HPC) as an indicator for CD34-positive cell counts in allogeneic peripheral blood stem cell harvest from G-CSF mobilized donor. Vox Sang. 2024; 119(S1)(575): P882.
- Pedrals S, Maglio L. Relation between mobilization protocol in stem cell apheresis and product purity. Vox Sang. 2024; 119(S1)(577): P886.
- Kim K, Goh R, Jeong J, et al. Analysis of cord blood units provided for transplantation in Korea over a 10-year period. Vox Sang. 2024; 119(S1)(569): P869.
- Lee H, Roh E, Kim N, et al. The impact of the cryopreserved period on the percentage of viable CD34+ cells among whole CD34+ cells of CB units. Vox Sang. 2024; 119(S1)(571): P872.
- Gómez-Vives D, Samarkanova D, Rierola M, et al. Umbilical cord blood platelet gel for cutaneous lesions in a patient with severe graft-versus-host disease. Vox Sang. 2024; 119(S1)(572): P873.
- Etxebarria A, Herrera L, Barriales D, et al. Generating NKG2D-CAR-transduced natural killer (NK) cells for treating osteosarcoma. Vox Sang. 2024; 119(S1)(573): P876.
- Herrera DVL, Barriales D, Etxebarria A, et al. Improving CAR-NK cells performance against target cells - comparative study of transduction enhancers in game. Vox Sang. 2024; 119(S1)(575): P880.
